Showing results 1 to 20 of 26
next >
| Preview | Issue Date | Title / Name | Author(s) | Type |
| 2020 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| Jan-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
 | Jun-2022 | Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry) | Gately, Lucy; Drummond, Katherine; Rosenthal, Mark; Harrup, Rosemary; Dowling, Anthony, et al | Journal Article | |
| 2018 | Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line setting | Conduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et al | Conference Paper | |
| 2022 | CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort | Javaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et al | Conference Paper | |
 | 2016 | Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer | Tie, Jeanna; Wang, Yuxuan; Tomasetti, Cristian; Li, Lu; Springer, Simeon, et al | Journal Article | |
 | Jun-2022 | Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | Tie, Jeanna; Cohen, Joshua D.; Lahouel, Kamel; Lo, Serigne N.; Wang, Yuxuan, et al | Journal Article | |
 | 2024 | Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study | Tie, Jeanne; Cohen, Joshua D.; Yuxuan, Wang; Gonzalez Ginestet, Pablo; Wong, Rachel, et al | Conference Paper | |
| 10-Nov-2023 | A combined analysis of two randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma | Gately, Lucy; Mesia, Carlos; Sepulveda, Juan; del Barco, Sonia; Pineda, Estela, et al | Conference Paper | |
| Nov-2020 | Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer | Collins, Ian M.; Kanjanapan, Yada; Wen Lok, Sheau; Gibbs, Peter; De Boer, Richard, et al | Journal Article | |
 | 26-Jun-2024 | Improving Clinical Registry Data Quality via Linkage With Survival Data From State-Based Population Registries | Smith, Samuel; Drummond, Kate; Dowling, Anthony; Bennett, Iwan; Campbell, David, et al | Journal Article | |
| 10-Nov-2023 | Linking data from a brain cancer clinical registry (brain) with the state-based registry of births deaths marriages: improving the quality of clinical registry survival data | Smith, Samuel; Drummond, Kate; Dowling, Anthony; Bennett, Iwan; Freilich, Ronnie, et al | Conference Paper | |
| 2018 | Management of brainmetastases in patients with HER2 positive breast cancer-a real world Australian experience | Moldovan, Cristina A.; King, Rossa; Lok, Sheau Wen; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| 31-May-2023 | Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry. | Wen Lok, Sheau; Tung, Iris; Anton, Angelyn; Baron-Hay, Sally E.; De Boer, Richard H., et al | Conference Paper | |
 | 29-May-2024 | Real world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer. | Wong, Vanessa; Loft, Matthew; Kosmider, Suzanne; Wong, Rachel; Shspiro, Jeremy David, et al | Conference Paper | |
| 2020 | Real world outcomes in elderly patients with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2021 | Real world outcomes in elderly women with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
 | 2020 | Real World Outcomes in Elderly Women with HER2-Positive Advanced Breast Cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| 2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer | Conduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et al | Journal Article | |
| 18-Nov-2024 | Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer | Loft, Matthew; Wong, Vanessa; Kosmider, Suzanne; Wong, Rachel; Shapiro, Jeremy, et al | Journal Article | |
